The European Commission (EC) has granted marketing authorisation for Eli Lilly’s Kisunla (donanemab), a treatment for early ...

GSK has confirmed that Dame Emma Walmsley will step down as its chief executive office (CEO) at the end of this year, with ...

True launch excellence demands bold innovation, deep market insight and flawless alignment across product, market and ...

Scientists at the University of Liverpool, UK, have identified a new class of antibiotic that shows strong activity against ...

The growing diversity of therapies – from widely used primary care treatments to highly specialised cell and gene treatments ...

Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a ...

Healthcare agency SAY Communications has chosen Overcoming MS, the world’s leading multiple sclerosis healthy lifestyle ...

Victoria House is the first location in London to combine incubator labs with fully serviced office space in a Grade II ...

Eli Lilly has announced its plans to build the second of four US manufacturing facilities at Generation Park in Houston, ...

The European Medicines Agency (EMA) has confirmed that recommendations on the use of paracetamol (acetaminophen) during ...

More than 558,000 new breast cancer cases are diagnosed annually and the disease claims around 145,000 lives each year’ ...

Investing in data analytics and AI tools can lead to smarter clinical trials and faster, more informed decisions ...